Skip to main content
. 2014 Aug 14;9(8):e105104. doi: 10.1371/journal.pone.0105104

Table 3. Validation of the results by qRT-PCR analysis.

Gene SK-OV-3cycling vs.control foldchange(array/qRT-PCR) SK-OV-3chronic vs.control foldchange(array/qRT-PCR) PC-3 cyclingvs. controlfold change(array/qRT-PCR) PC-3 chronicvs. controlfold change(array/qRT-PCR) WM793Bcycling vs.controlfoldchange(array/qRT-PCR) WM793B chronic vs. control foldchange (array/qRT-PCR)
Il8 9.1/ 6.2# 1.8/2.2# 6.5/3.5 9.2/4.5 0.9/0.65 1.0/1.0
AREG 2.7/1.75# 0.15/0.5# 2.4/1.8* 1.15/0.8* Low or noexpression Low or noexpression
HBEGF 5.7/2.25# 1.0/1.45# 3.0/0.86 2.4/1.8 Low/1.45 Low/0.75
EPHA2 4.4/2.2* 1.8/2.1* 1.0/1.3* 0.82/0.8* 1.3/1.25* 0.9/1.0
PLAU 4.2/1.8 2.1/1.6 2.4/2.1* 1.4/0.6* Low or noexpression Low or noexpression
CXCL2 2.3/2.9# 0.25/1.6 3.4/3.1* 3.7/2.3* 0.2/0.3* 0.8/0.7

In bold are results showing the differential gene expression between cycling and chronic samples assessed by qRT-PCR. The results marked with * are statistically significant (p<0.05; U Mann-Whitney test), whereas those marked with # have p = 0.051.